EP1530720A4 - Programm zur ausrottung von brustkrebs - Google Patents

Programm zur ausrottung von brustkrebs

Info

Publication number
EP1530720A4
EP1530720A4 EP02780675A EP02780675A EP1530720A4 EP 1530720 A4 EP1530720 A4 EP 1530720A4 EP 02780675 A EP02780675 A EP 02780675A EP 02780675 A EP02780675 A EP 02780675A EP 1530720 A4 EP1530720 A4 EP 1530720A4
Authority
EP
European Patent Office
Prior art keywords
breast cancer
eradication program
cancer eradication
program
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02780675A
Other languages
English (en)
French (fr)
Other versions
EP1530720A2 (de
Inventor
David A Sirbasku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signe BioPharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP10185007A priority Critical patent/EP2306187A1/de
Priority to EP10184998A priority patent/EP2299265A1/de
Publication of EP1530720A2 publication Critical patent/EP1530720A2/de
Publication of EP1530720A4 publication Critical patent/EP1530720A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP02780675A 2001-11-13 2002-11-13 Programm zur ausrottung von brustkrebs Withdrawn EP1530720A4 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP10185007A EP2306187A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm
EP10184998A EP2299265A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33803701P 2001-11-13 2001-11-13
US338037P 2001-11-13
PCT/US2002/036632 WO2003042404A2 (en) 2001-11-13 2002-11-13 Breast cancer eradication program

Publications (2)

Publication Number Publication Date
EP1530720A2 EP1530720A2 (de) 2005-05-18
EP1530720A4 true EP1530720A4 (de) 2005-08-31

Family

ID=23323133

Family Applications (3)

Application Number Title Priority Date Filing Date
EP02780675A Withdrawn EP1530720A4 (de) 2001-11-13 2002-11-13 Programm zur ausrottung von brustkrebs
EP10184998A Withdrawn EP2299265A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm
EP10185007A Withdrawn EP2306187A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP10184998A Withdrawn EP2299265A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm
EP10185007A Withdrawn EP2306187A1 (de) 2001-11-13 2002-11-13 Krebsausrottungsprogramm

Country Status (3)

Country Link
EP (3) EP1530720A4 (de)
AU (1) AU2002343714A1 (de)
WO (1) WO2003042404A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011092A (es) 2000-05-10 2004-08-19 David A Sirbasku Composiciones y metodos para demostrar la regulacion del sistema inmune secretor del crecimiento de la celula de cancer que responde a la hormona esteroidea.
EP1530720A4 (de) 2001-11-13 2005-08-31 David A Sirbasku Programm zur ausrottung von brustkrebs
WO2010097797A1 (en) 2009-02-27 2010-09-02 No Screw Ltd. Cutting tool, cutting tool holder and cutting insert therefor
CN104955452B (zh) * 2013-09-05 2017-06-09 普惠德生技股份有限公司 含有亚铁氨基酸螯合物的组合物在制备抗癌症的药物中的用途
TWI483721B (zh) 2013-09-05 2015-05-11 Profeat Biotechnology Co Ltd The use of a composition containing a ferrous amino acid chelate for the manufacture of anti-cancer medicaments
WO2018098804A1 (zh) * 2016-12-02 2018-06-07 普惠德生技股份有限公司 含有亚铁氨基酸螯合物的组合物用于制造防止癌症转移的医药品的用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
EP0246734A1 (de) * 1986-03-21 1987-11-25 Efamol Holdings Plc Eisen enthaltende Zusammensetzung und Verfahren zur Behandlung von Krebs
WO1996040108A1 (en) * 1995-06-07 1996-12-19 Washington University Multidentate metal complexes and methods of making and using thereof
WO2001086307A2 (en) * 2000-05-10 2001-11-15 Sirbasku David A Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683200A (en) * 1984-05-17 1987-07-28 Setsuo Hirohashi Monoclonal antibody to human cancer antigen and method for producing same
RU1837891C (ru) * 1991-01-31 1993-08-30 Keshelava Viktor V Способ получени противоопухолевого средства
US6200547B1 (en) * 1994-01-26 2001-03-13 Ferx Incorporated Magnetically responsive compositions for carrying biologically active substances and methods of production and use
CA2316397A1 (en) * 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
EP1530720A4 (de) 2001-11-13 2005-08-31 David A Sirbasku Programm zur ausrottung von brustkrebs

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
EP0246734A1 (de) * 1986-03-21 1987-11-25 Efamol Holdings Plc Eisen enthaltende Zusammensetzung und Verfahren zur Behandlung von Krebs
WO1996040108A1 (en) * 1995-06-07 1996-12-19 Washington University Multidentate metal complexes and methods of making and using thereof
WO2001086307A2 (en) * 2000-05-10 2001-11-15 Sirbasku David A Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
US20020006630A1 (en) * 2000-05-10 2002-01-17 Sirbasku David A. Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
US20020012954A1 (en) * 2000-05-10 2002-01-31 Sirbasku David A. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth

Also Published As

Publication number Publication date
EP2299265A1 (de) 2011-03-23
EP1530720A2 (de) 2005-05-18
WO2003042404A3 (en) 2003-12-31
AU2002343714A1 (en) 2003-05-26
EP2306187A1 (de) 2011-04-06
WO2003042404A2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
AU2002360769A8 (en) Breast cancer expression profiling
IL251270A0 (en) Cancer treatment
GB2380411B (en) Breast pumps
AU2002351374A8 (en) Antibodies to treat cancer
GB0110847D0 (en) Breast cancer detection
GB0005257D0 (en) Breast cancer hormonal therapy
EP1530720A4 (de) Programm zur ausrottung von brustkrebs
AU2002360815A8 (en) Human breast cancer biomarkers
GB0026015D0 (en) Cancer treatment
HK1076150A (en) Breast cancer eradication program
EP1463511A4 (de) Kombinationskrebstherapie
GB2382019B (en) Brassiere
GB2371465B (en) Shoe tree
CA96410S (en) Breast feeding tee-shirt
CA96408S (en) Breast feeding tee-shirt
CA96409S (en) Breast feeding tee-shirt
CA94330S (en) Breast feeding nightdress
GB0122410D0 (en) Cancer diagnosis
GB0127668D0 (en) Cancer
GB0123630D0 (en) cancer
GB0115673D0 (en) Cancer
CA96411S (en) Breast feeding bra
TW527869U (en) Improved bra
TW511465U (en) Improved bra
GB0104373D0 (en) Breast pad

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050110

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20050714

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076150

Country of ref document: HK

17Q First examination report despatched

Effective date: 20060303

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIGNE BIOPHARMA INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SIRBASKU, DAVID A.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIGNE BIOPHARMA INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALN20080528BHEP

Ipc: A61F 13/00 20060101ALI20080528BHEP

Ipc: A01N 61/00 20060101ALI20080528BHEP

Ipc: A61K 31/00 20060101ALI20080528BHEP

Ipc: G01N 33/48 20060101AFI20080528BHEP

Ipc: A61F 2/00 20060101ALI20080528BHEP

Ipc: A01N 37/18 20060101ALI20080528BHEP

Ipc: A61K 38/00 20060101ALI20080528BHEP

Ipc: A61K 51/00 20060101ALI20080528BHEP

Ipc: A61M 36/14 20060101ALI20080528BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1076150

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150602